You have 9 free searches left this month | for more free features.

Mesnex

Showing 1 - 25 of 86

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Neuroblastoma, Pediatric Cancer Trial in New York (Cyclophosphamide, Topotecan, Vincristine)

Recruiting
  • Neuroblastoma
  • Pediatric Cancer
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 11, 2023

Lymphoma Trial in Houston (Radiation Therapy, Dexamethasone, Etoposide phosphate)

Recruiting
  • Lymphoma
  • Radiation Therapy
  • +5 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 9, 2022

Anemia, Sickle Cell Trial in New York (Siplizumab, Exchange Transfusion, Total Body Irradiation)

Recruiting
  • Anemia, Sickle Cell
  • New York, New York
    Columbia University Irving Medical Center
Oct 9, 2023

Liver Transplant Trial in Boston (biological, procedure, drug)

Recruiting
  • Liver Transplant
  • arTreg-CSB
  • +4 more
  • Boston, Massachusetts
    Massachusetts General Hospital: Transplantation
Jan 30, 2023

Testicular Cancer Trial in Houston, Seattle (Gemcitabine, Docetaxel, Melphalan)

Active, not recruiting
  • Testicular Cancer
  • Houston, Texas
  • +1 more
Dec 5, 2022

Stem Cell Transplant Complications, Graft Vs Host Disease, Myeloid Leukemia, Acute Trial in Boston (radiation, drug, biological,

Recruiting
  • Stem Cell Transplant Complications
  • +4 more
  • Radiation
  • +7 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jan 19, 2023

Liver Transplant Trial in San Francisco (biological, procedure, drug)

Recruiting
  • Liver Transplant
  • arTreg
  • +4 more
  • San Francisco, California
    University of California, San Francisco
Sep 13, 2022

Aplastic Anemia, Bone Marrow Failure Syndrome Trial in Memphis (drug, radiation, device, biological)

Recruiting
  • Aplastic Anemia
  • Bone Marrow Failure Syndrome
  • Anti-Thymocyte Globulin (Rabbit)
  • +8 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Aug 26, 2022

Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia, Refractory Trial in Memphis (drug, device, biological)

Active, not recruiting
  • Acute Lymphoblastic Leukemia, in Relapse
  • Acute Lymphoblastic Leukemia, Refractory
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Jan 3, 2023

Leukemia, Lymphoma Trial in Memphis (radiation, drug, biological, device)

Completed
  • Leukemia
  • Lymphoma
  • Total Lymphoid Irradiation
  • +10 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Oct 28, 2022

Crohn Disease Trial in Los Angeles (drug, procedure, biological)

Recruiting
  • Crohn Disease
  • Los Angeles, California
    Cedars-Sinai Medical Center
Mar 23, 2022

Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial (drug, radiation, procedure)

Not yet recruiting
  • Acute Leukemia
  • +4 more
  • (no location specified)
Oct 18, 2022

Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia, Refractory, Pediatric ALL Trial in Memphis (biological,

Recruiting
  • Acute Lymphoblastic Leukemia, in Relapse
  • +2 more
  • CD19-CAR(Mem) T-cells
  • +5 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Aug 5, 2022

Hematologic Malignancy, Myeloid Malignancy Trial in Memphis (Ruxolitinib, Mesna, Anti-thymocyte globulin (ATG))

Recruiting
  • Hematologic Malignancy
  • Myeloid Malignancy
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Nov 7, 2022

Retinoblastoma Trial in Memphis (drug, other, procedure, radiation)

Recruiting
  • Retinoblastoma
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Aug 25, 2022

B-Lymphoid Malignancies, Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia Trial in Houston (Fludarabine,

Active, not recruiting
  • B-Lymphoid Malignancies
  • +3 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Aug 1, 2022

Hematologic Malignancy Trial in New York (melphalan, fludarabine, thiotepa)

Active, not recruiting
  • Hematologic Malignancy
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 21, 2022

Pediatric Solid Tumor, Osteosarcoma, Rhabdomyosarcoma Trial in Memphis (Fludarabine, Cyclophosphamide, MESNA)

Recruiting
  • Pediatric Solid Tumor
  • +15 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Jun 30, 2022

Acute Leukemia, MDS, T-lymphoblastic Lymphoma Trial (drug, radiation, procedure)

Not yet recruiting
  • Acute Leukemia
  • +6 more
  • (no location specified)
Dec 8, 2021

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Leukemia Trial in United States (drug, procedure, other, radiation)

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +10 more
  • Jacksonville, Florida
  • +5 more
Aug 14, 2023

Ewing's Family Tumors, Renal Tumors, Hepatoblastoma Trial in Minneapolis (drug, biological, radiation, procedure)

Recruiting
  • Ewing's Family Tumors
  • +11 more
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Apr 11, 2022

Lymphoma, Non-Hodgkin, Advanced Stage Diffuse Large B-Cell Non-Hodgkin's Lymphoma Trial in Vancouver (Cyclophosphamide,

Active, not recruiting
  • Lymphoma, Non-Hodgkin
  • Advanced Stage Diffuse Large B-Cell Non-Hodgkin's Lymphoma
  • Vancouver, British Columbia, Canada
    BC Cancer Agency
Jul 20, 2021

Acute Leukemia, MDS, T-lymphoblastic Lymphoma Trial (drug, radiation, procedure)

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +6 more
  • Bone Marrow Hematopoeitic Cell Transplant (HCT)
  • +9 more
  • (no location specified)
Sep 27, 2021

Mantle-Cell Lymphoma Trial in Miami (G-CSF, Rituximab, Cyclophosphamide)

Active, not recruiting
  • Mantle-Cell Lymphoma
  • G-CSF
  • +10 more
  • Miami, Florida
    University of Miami
Aug 12, 2021

Multiple Sclerosis, Relapsing-Remitting Trial in Chicago (Cyclophosphamide, Mesna, rATG)

Terminated
  • Multiple Sclerosis, Relapsing-Remitting
  • Chicago, Illinois
    Northwestern University
Jan 6, 2021